ConductScience.org, home

Paper408154

Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin.

Bergman Y and 1 other. Eur J Immunol, 1977. Cited by 186 papers, by iCite.

Cite this record

ConductScience Library. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Papers, record 408154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/408154

Download JSON
Cell line
38C132 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin.
PubMed
Journal
Eur J Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
186
iCite
Relative citation ratio, by iCite
3.66
iCite
Revised in PubMed
2005-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bergman YY
2Haimovich JJ

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-LymphocytesMajor topic
Neoplasms, ExperimentalMajor topic
9,10-Dimethyl-1,2-benzanthracene
Animals
Cell Line
Clone Cells
Electrophoresis, Polyacrylamide Gel
Fluorescent Antibody Technique
Immunoglobulin Fc Fragments
Immunoglobulins
Isoelectric Focusing
Mice
Mice, Inbred C3H
Receptors, Antigen, B-Cell

Source PubMed

Download CSV of topics

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.

PMIDTitleJournalYearIn PapersSource
23719241Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.J Immunother2013https://conductscience.org/library/papers/23719241PubMed
23121670Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma.Clin Exp Immunol2012https://conductscience.org/library/papers/23121670PubMed
22400032Murine models of B-cell lymphomas: promising tools for designing cancer therapies.Adv Hematol2012https://conductscience.org/library/papers/22400032PubMed
20053640ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).Protein Eng Des Sel2010https://conductscience.org/library/papers/20053640PubMed
19894105Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.Pharm Res2010https://conductscience.org/library/papers/19894105PubMed
19690034Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.J Nucl Med2009https://conductscience.org/library/papers/19690034PubMed
19018479Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors.Immunol Res2008https://conductscience.org/library/papers/19018479PubMed
17993615Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.Blood2008https://conductscience.org/library/papers/17993615PubMed
17876582Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.Cancer Immunol Immunother2008https://conductscience.org/library/papers/17876582PubMed
17351111A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.Blood2007https://conductscience.org/library/papers/17351111PubMed
17164345Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.Blood2007https://conductscience.org/library/papers/17164345PubMed
16034559Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?Cancer Immunol Immunother2006https://conductscience.org/library/papers/16034559PubMed
12857988Rational approaches to immune regulation.Immunol Res2003https://conductscience.org/library/papers/12857988PubMed
10505101Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype.Gene Ther1999https://conductscience.org/library/papers/10505101PubMed
10404515An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.Mol Med1999https://conductscience.org/library/papers/10404515PubMed
10096292Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.Nat Biotechnol1999https://conductscience.org/library/papers/10096292PubMed
9892697Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/9892697PubMed
9380720Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9380720PubMed
8855293Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8855293PubMed
8469286Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma.Nature1993https://conductscience.org/library/papers/8469286PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/408154

GET https://conductscience.org/api/papers/v1/408154/cited_by?page=2